Showing results (481-490 of 541) with videos related to
Sort By:
Pageof 55
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2016
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.British Journal of Cancer|December 22, 2021
Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary careBrian D Nicholson, José M Ordóñez-Mena, Sarah Lay-Flurrie, et al.Vaccine|February 17, 2020
ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinationsMiriam Sturkenboom, Toon Braeye, Lieke van der Aa, et al.JMIR Public Health and Surveillance|October 28, 2020
COVID-19 Surveillance in a Primary Care Sentinel Network: In-Pandemic Development of an Application OntologySimon de Lusignan, Harshana Liyanage, Dylan McGagh, et al.Nature Communications|March 16, 2024
Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohortsSarah J Aldridge, Utkarsh Agrawal, Siobhán Murphy, et al.BMC Public Health|June 10, 2022
National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidanceThierry Rigoine de Fougerolles, Oliver Damm, Filippo Ansaldi, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 5, 2015
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season resultsRichard Pebody, Fiona Warburton, Nick Andrews, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 25, 2023
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Mark Joy, Rachel Byford, et al.JMIR Formative Research|July 5, 2022
Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United KingdomGayathri Delanerolle, Robert Williams, Ana Stipancic, et al.The Lancet. Infectious Diseases|May 19, 2020
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studySimon de Lusignan, Jienchi Dorward, Ana Correa, et al.Pageof 55